Quick10K

⚲

Novo Integrated Sciences

Filings

10-Q	2020-11-30	Filed 2021-01-13
10-K	2020-08-31	Filed 2020-12-09
10-Q	2020-05-31	Filed 2020-07-14
10-Q	2020-02-29	Filed 2020-04-20
10-Q	2019-11-30	Filed 2020-01-13
10-K	2019-08-31	Filed 2019-11-20
10-Q	2019-05-31	Filed 2019-07-11
10-Q	2019-02-28	Filed 2019-04-11
10-Q	2018-11-30	Filed 2019-01-11
10-K	2018-08-31	Filed 2018-11-06
10-Q	2018-05-31	Filed 2018-07-11
10-Q	2018-02-28	Filed 2018-04-12
10-Q	2017-11-30	Filed 2018-01-12
10-K	2017-08-31	Filed 2017-12-08
10-Q	2017-05-31	Filed 2017-07-24
10-Q	2017-03-31	Filed 2017-04-14
10-K	2016-12-31	Filed 2017-03-07
10-Q	2016-09-30	Filed 2016-10-31
10-Q	2016-06-30	Filed 2016-07-22
10-Q	2016-03-31	Filed 2016-04-29
10-K	2015-12-31	Filed 2016-03-25
10-Q	2015-09-30	Filed 2015-10-30
10-Q	2015-06-30	Filed 2015-07-31
10-Q	2015-03-31	Filed 2015-05-01
10-K	2014-12-31	Filed 2015-03-27
10-Q	2014-09-30	Filed 2014-11-05
10-Q	2014-06-30	Filed 2014-08-01
10-Q	2014-03-31	Filed 2014-05-19
10-K	2013-12-31	Filed 2014-04-16
10-Q	2013-09-30	Filed 2013-11-19
10-Q	2013-06-30	Filed 2013-08-16
10-Q	2013-03-31	Filed 2013-05-20
10-K	2012-12-31	Filed 2013-04-15
10-Q	2012-09-30	Filed 2012-11-23
10-Q	2012-06-30	Filed 2012-08-20
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-04-06
10-Q	2011-09-30	Filed 2011-11-21
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-03-31
10-Q	2010-09-30	Filed 2010-11-15
10-Q	2010-06-30	Filed 2010-08-16
10-Q	2010-03-31	Filed 2010-05-17
10-K	2009-12-31	Filed 2010-04-14

Reports

8-K	2020-11-23
8-K	2020-11-09
8-K	2020-10-19
8-K	2020-08-06
8-K	2020-07-21
8-K	2020-04-07
8-K	2020-03-20
8-K	2020-03-09
8-K	2020-02-04
8-K	2019-12-17
8-K	2019-10-23
8-K	2019-09-24
8-K	2019-09-11
8-K	2019-03-06
8-K	2019-02-26
8-K	2019-02-20
8-K	2019-01-31
8-K	2019-01-14
8-K	2018-12-18
8-K	2018-11-30
8-K	2018-11-23
8-K	2018-11-14
8-K	2018-10-23
8-K	2018-10-17
8-K	2018-10-10
8-K	2018-07-27
8-K	2018-05-31
8-K	2018-04-08
8-K	2018-03-19
8-K	2018-03-15
8-K	2018-01-30
8-K	2018-01-16
8-K	2017-12-29
8-K	2017-12-26

Novo Integrated Sciences Financials

NVOS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash	7	9	12	11	24	6	25	0	1	3	12	0	6	2	9	8	9	14	34	17	13	54	15	1,674	1,897	1,296	1,037	864	676	929	2,374	2,478
Accounts Receivable																								855	1,129	1,289	1,349	1,312	1,338	1,405	1,379	1,383
Inventory
PP&E	52	51	7	6	19	70	16	15	14	70	12	10	9	37	6	0	0	1						520	571	559	609	641	729	790	800	806
Assets	178	164	26	226	275	35	49	22	379	358	295	201	133	23	29	22	22	28	47	31	27	70	37	5,389	5,514	4,958	5,072	4,840	4,743	5,062	29,081	31,682
Accounts Payable	134	119	116	75	124	118	120	163	160	146	134	161	77	83	101	56	12	13	27	9	3	20	5	1,895	1,703	1,575	1,744	1,310	1,308	1,368	1,254	1,284
Long-Term Debt					649	687	813	773	446	117	192	244	272	308	0	0	0	0						406	428	408	411	406	0	0	0	0
Liabilities	2,058	2,244	2,354	2,055	797	832	974	957	1,263	1,306	1,221	1,345	714	648	101	56	12	13	27	9	3	20	5	9,938	9,803	9,339	4,719	4,556	4,570	4,545	4,252	6,368
Stockholders' Equity	-1,879	-2,080	-2,328	-1,829	-522	-797	-925	-935	-884	-948	-925	-1,145	-580	-626	-73	-34	10	15	20	22	24	50	32	-4,531	-4,268	-4,358	379	310	201	551	24,866	25,351


Income Statement ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Revenue																								2,090	2,220	2,254	2,310	2,323		2,312	2,200	2,490
Cost of Revenue																								1,377	1,255	1,408	1,338	1,418	1,338	1,428	1,321	1,557
Gross Profit																								713	966	846	971	905	834	884	880	933
R&D	87	0	43	0		0	0	0	0	0	0	0	0	0	0	0	25	0	0		0	0
SG&A																								974	928	1,018	2,010	1,082	927	1,099	958	996
Tax																								0	0	0	0	0	0	0	0	0
Net Income	-485	-501	-417	-409	-199	-165	-243	-283	-169	-192	-146	-327	-209	-328	-2,360	-362	-13	-35	-68	-17	-37	-42	-37	-357	-616	-357	-1,375	-218	-158	-251	-120	-99


Cash Flow ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating		-35		-145		-45	-49	-90	-70	-40	-42	-32	-31	-40	-26	-85	-50	-15	-21	-46	-20	-23	-54	-298	-724	-352	-421		-94	-163	-297	-71
Cash Investing		0		-198		0	0	0	0	0	0	0	0	-1					0	0	0	0	0	-392	-750	-24	-83		-94	-74	-227	-404
Cash Financing		37		342		28	68	65	71	43	51	20	37	38	33	85	50	20	40	30	15	65	15	2,160	3,023	-184	-286		11	497	1,940	639